NCT04532957View on ClinicalTrials.gov

A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

October 8, 2020

Study Completion Date

October 15, 2020

Conditions

Healthy

Interventions

DRUG

KBP-7072

QD oral capsules

DRUG

Placebo

matching placebo capsules

Trial Locations (1)

32117

Covance Clinical Research Unit, Daytona Beach

Sponsors

Lead Sponsor

KBP Biosciences

Collaborators (1)

All Listed Sponsors

collaborator

Covance

INDUSTRY

lead

KBP Biosciences

INDUSTRY